Hope for rare disorder: drug trial aims to stop dangerous blood sugar crashes
NCT ID NCT06067802
Summary
This study is testing if a medication called triheptanoin can safely prevent low blood sugar (hypoglycemia) in adults with a rare inherited condition called MCADD. Eight participants will take the drug for about 9 weeks while researchers monitor for side effects and check if it helps normalize certain blood and urine markers related to the disease. The trial involves three overnight hospital stays with controlled fasting periods to see how well the body handles stress.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MEDIUM CHAIN ACYL COA DEHYDROGENASE DEFICIENCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UPMC Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, 15224, United States
Conditions
Explore the condition pages connected to this study.